Historical Perspectives in Hemostasis, Coagulation, and Fibrinolysis: A Foundation for Understanding Thrombotic Disorders and Developing Effective Treatment

2006 ◽  
Author(s):  
Richard C. Becker ◽  
Frederick A. Spencer
Keyword(s):  
Serine Protease ◽  
Domain Structure ◽  
Vitamin K ◽  
Serine Proteases ◽  
Protein C ◽  
Blood Clot ◽  
Amino Acid Residues ◽  
Serine Protease Domain ◽  
Gene Structures ◽  
The Individual

Hemostasis, the prompt cessation of bleeding at a site of vascular injury, is among the most fundamental physiologic and teleologically vital defense mechanisms in nature. Without a functionally intact hemostatic mechanism, death could ensue rapidly even after minor traumas associated with everyday life. In mammalian blood coagulation, regulated by a complex network of integrated biochemical events, five protease factors (f ) (fIIa [thrombin], fVIIa, fIXa, fXa, and protein C) interact with five cofactors (tissue factor, f VIIIa, fVa, thrombomodulin, and protein S) to regulate the generation of fibrin (Davidson et al., 2003). Although each component of the mammalian coagulation network has unique functional properties, available data based on gene organizations, protein structure, and sequence analysis suggest that it may have resulted from the reduplication and diversification of two gene structures over 400 million years ago. A vitamin K–dependent serine protease is composed of a γ-carboxylated glutamic acid (GLA) epidermal growth factor-like (EGF) 1–EGF 2-serine protease domain structure common to fVII, fIX, fX, and protein C, and the A1-A2-B-AB-C1-C2 domain structure common to fV and fVIII. Prothrombin is also a vitamin K–dependent serine protease; however, it contains kringle domains rather than EGF domains (suggesting a replacement during gene duplication and shuffling). Analyses of active site function amino acid residues reveal distinguishing characteristics of thrombin from other serine proteases, supporting its position as the ancestral blood enzyme (Krem and Cera, 2002; McLysaght et al., 2002). The rapid transformation of fluid blood to a gel-like substance (clot) has been a topic of great interest to scientists, physicians, and philosophers since the days of Plato and Aristotle ( Jewett, 1892; Lee, 1952). However, it was not until the beginning of the 18th century that blood clotting (coagulation) was appreciated as a means to stem blood loss from wounds (hemostasis) (Petit, 1731). As with other areas of science, the microscope played a pivotal role in the understanding of coagulation. In the mid-17th century, Marcello Malpighi separated the individual components of a blood clot into fibers, cells, and serum (Forester, 1956).

scholarly journals Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation

Blood ◽  
1982 ◽  
Vol 60 (1) ◽  
pp. 261-264 ◽  
Author(s):  
JH Griffin ◽  
DF Mosher ◽  
TS Zimmerman ◽  
AJ Kleiss
Keyword(s):  
Liver Disease ◽  
Serine Protease ◽  
Vitamin K ◽  
Protein C ◽  
Activated Protein C ◽  
Coagulation System ◽  
Antigen Concentration ◽  
Intravascular Coagulation ◽  
The Mean

Abstract Activated protein C is a potent anticoagulant and profibrinolytic enzyme that can be derived from the vitamin-K-dependent serine protease zymogen, protein C, by the action of thrombin. Protein C antigen concentration was determined in plasmas from normals (n = 40) and from 38 patients with intravascular coagulation as evidenced by positive FDP (greater than micrograms/ml). Plasma protein C was 4 micrograms/ml in normals and was significantly depressed (less than 2 SD below the mean of normals) in 19 of the 38 patients. Of 15 patients with suspected intravascular coagulation but normal FDP, protein C was decreased in 5 individuals; 3 of these 5 patients had liver disease. Based on these results, we suggest that extensive activation of the coagulation system in vivo causes a significant consumption of protein C, presumably due to its activation by thrombin and subsequent clearance.

scholarly journals Immunogenic Properties of Recombinant Enzymes from Bothrops ammodytoides towards the Generation of Neutralizing Antibodies against Its Own Venom

Toxins ◽  
2019 ◽  
Vol 11 (12) ◽  
pp. 702
Author(s):  
Herlinda Clement ◽  
Ligia Luz Corrales-García ◽  
Damaris Bolaños ◽  
Gerardo Corzo ◽  
Elba Villegas
Keyword(s):  
Serine Protease ◽  
Serine Proteases ◽  
Neutralizing Antibodies ◽  
Venom Gland ◽  
Amino Acid Residues ◽  
Recombinant Enzymes ◽  
E Coli ◽  
Molecular Masses ◽  
Topo Vector ◽  
Immunogenic Properties

Bothropic venoms contain enzymes such as metalloproteases, serine-proteases, and phospholipases, which acting by themselves, or in synergism, are the cause of the envenomation symptoms and death. Here, two mRNA transcripts, one that codes for a metalloprotease and another for a serine-protease, were isolated from a Bothrops ammodytoides venom gland. The metalloprotease and serine-protease transcripts were cloned on a pCR®2.1-TOPO vector and consequently expressed in a recombinant way in E. coli (strains Origami and M15, respectively), using pQE30 vectors. The recombinant proteins were named rBamSP_1 and rBamMP_1, and they were formed by an N-terminal fusion protein of 16 amino acid residues, followed by the sequence of the mature proteins. After bacterial expression, each recombinant enzyme was recovered from inclusion bodies and treated with chaotropic agents. The experimental molecular masses for rBamSP_1 and rBamMP_1 agreed with their expected theoretical ones, and their secondary structure spectra obtained by circular dichroism were comparable to that of similar proteins. Additionally, equivalent mixtures of rBamSP_1, rBamMP_1 together with a previous reported recombinant phospholipase, rBamPLA2_1, were used to immunize rabbits to produce serum antibodies, which in turn recognized serine-proteases, metalloproteases and PLA2s from B. ammodytoides and other regional viper venoms. Finally, rabbit antibodies neutralized the 3LD50 of B. ammodytoides venom.

Structure of the Human Factor VII Gene

1987 ◽  
Author(s):  
Patrick J O'hara ◽  
Frank A Grant ◽  
A Betty ◽  
J Haldmen ◽  
Mark J Murray
Keyword(s):  
Serine Protease ◽  
Vitamin K ◽  
Protein C ◽  
Tandem Repeats ◽  
Human Factor ◽  
Factor Ix ◽  
Factor Vii ◽  
Factor X ◽  
X Protein ◽  
Additional Exon

Factor VII is a member of a family of vitamin K-dependent, gamma-carboxylated plasma protein which includes factor IX, factor X, protein C, protein S and prothrombin. Activated factor VII (factor Vila) is a plasma serine protease which participates in a cascade of reactions leading to the coagulation of blood. Two overlapping genomic clones containing sequences encoding human factor VII were isolated and characterized. The complete sequence of the gene was determined and found to span 12.8 kilobases. The mRNA for factor VII as demonstrated by cDNA cloning is polyadenylated at multiple sites but contains only one AAUAAA poly-A signal sequence. The mRNA can undergo alternative splicing forming one transcript containing eight segments as exons and another with an additional exon which encodes a larger pre-pro leader sequence. The portion of the pre-pro leader coded for by the additional exon has no known counterpart in the other vitamin K-dependent proteins. The positions of the introns with respect to the amino acid sequence encoded by the eight essential exons of factor VII are the same as those present in factor IX, factor X, protein C and the first three exons of prothrombin. These exons code for domains generally conserved among members of this gene family, including a pre-pro leader (the essential exon la and alternative exon lb), a gamma-carboxylated domain (exons 2 and 3) a growth factor domain (exons 4 and 5) an activation region (exon 6) and a serine protease (exon 8). The corresponding introns in these genes are dissimilar with respect to size and sequence, with the exception of the third intron in factor VII and protein C. Four introns and a portion of exon 8 in factor VII contain regions made up of tandem repeats of oligonucleotide monomer elements. More than a quarter of the intron sequences and more than a third of the 3' untranslated portion of the mRNA transcript consist of these minisatellite tandem repeats. This type of structure is responsible for polymorphisms due to allelic variation in repeat copy number in other areas of the human genome. Tandem repeats can evolve as a result of random crossover in DNA whose sequence is not maintained by selection. This suggests that much of the sequence information present in the introns and untranslated portion of the message is dispensable.

scholarly journals A Clip Domain Serine Protease Involved in Egg Production in Nilaparvata lugens: Expression Patterns and RNA Interference

Insects ◽  
2019 ◽  
Vol 10 (11) ◽  
pp. 378 ◽  
Author(s):  
Jia-min Wu ◽  
Rong-er Zheng ◽  
Rui-juan Zhang ◽  
Jin-liang Ji ◽  
Xiao-ping Yu ◽  
...  
Keyword(s):  
Rna Interference ◽  
Serine Protease ◽  
Serine Proteases ◽  
Egg Production ◽  
Developmental Stages ◽  
Fat Body ◽  
Expression Patterns ◽  
Nilaparvata Lugens ◽  
Immune Functions ◽  
Serine Protease Domain

Clip domain serine proteases play vital roles in various innate immune functions and in embryonic development. Nilaparvata lugens proclotting enzymes (NlPCEs) belong to this protease family. NlPCE1 was reported to be involved in innate immunity, whereas the role of other NlPCEs is unclear. In the present study, N. lugens proclotting enzyme-3 (NlPCE3) was cloned and characterized. NlPCE3 contains a signal peptide, a clip domain, and a trypsin-like serine protease domain. NlPCE3 was expressed in all tissues examined (gut, fat body, and ovary), and at all developmental stages. Immunofluorescence staining showed that NlPCE3 was mainly expressed in the cytoplasm and cytomembrane of follicular cells. Double stranded NlPCE3 RNA interference clearly inhibited the expression of NlPCE3, resulting in abnormal egg formation and obstruction of ovulation. These results indicate that NlPCE3 plays an important role in egg production in N. lugens.

scholarly journals A molecular model of a point mutation (Val297Met) in the serine protease domain of protein C

1999 ◽  
Vol 31 (1) ◽  
pp. 47-51 ◽  
Author(s):  
Kyung Soon Song ◽  
Young Sook Park ◽  
Jong Rak Choi ◽  
Hyun Kyung Kim ◽  
Quehn Park
Keyword(s):  
Serine Protease ◽  
Point Mutation ◽  
Protein C ◽  
Molecular Model ◽  
Protease Domain ◽  
Serine Protease Domain

scholarly journals Amino acids 225-235 of the protein C serine-protease domain are important for the interaction with the thrombin-thrombomodulin complex

FEBS Letters ◽  
1995 ◽  
Vol 367 (2) ◽  
pp. 153-157 ◽  
Author(s):  
A. Vincenot ◽  
P. Gaussem ◽  
J.L. Pittet ◽  
S. Debost ◽  
M. Aiach
Keyword(s):  
Amino Acids ◽  
Serine Protease ◽  
Protein C ◽  
Protease Domain ◽  
Serine Protease Domain

scholarly journals Protein C, an antithrombotic protein, is reduced in hospitalized patients with intravascular coagulation

Blood ◽  
1982 ◽  
Vol 60 (1) ◽  
pp. 261-264 ◽  
Author(s):  
JH Griffin ◽  
DF Mosher ◽  
TS Zimmerman ◽  
AJ Kleiss
Keyword(s):  
Liver Disease ◽  
Serine Protease ◽  
Vitamin K ◽  
Protein C ◽  
Activated Protein C ◽  
Coagulation System ◽  
Antigen Concentration ◽  
Intravascular Coagulation ◽  
The Mean

Activated protein C is a potent anticoagulant and profibrinolytic enzyme that can be derived from the vitamin-K-dependent serine protease zymogen, protein C, by the action of thrombin. Protein C antigen concentration was determined in plasmas from normals (n = 40) and from 38 patients with intravascular coagulation as evidenced by positive FDP (greater than micrograms/ml). Plasma protein C was 4 micrograms/ml in normals and was significantly depressed (less than 2 SD below the mean of normals) in 19 of the 38 patients. Of 15 patients with suspected intravascular coagulation but normal FDP, protein C was decreased in 5 individuals; 3 of these 5 patients had liver disease. Based on these results, we suggest that extensive activation of the coagulation system in vivo causes a significant consumption of protein C, presumably due to its activation by thrombin and subsequent clearance.

Sign in / Sign up

Export Citation Format

Share Document